Cargando…
The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer
Cancer cells depend on cap-dependent translation more than normal tissue. This explains the emergence of proteins involved in the cap-dependent translation as targets for potential anticancer drugs. Cap-dependent translation starts when eIF4E binds to mRNA cap domain. This review will present eIF4E&...
Autores principales: | Karaki, Sara, Andrieu, Claudia, Ziouziou, Hajer, Rocchi, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185574/ https://www.ncbi.nlm.nih.gov/pubmed/26572974 http://dx.doi.org/10.1016/bs.apcsb.2015.09.001 |
Ejemplares similares
-
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2017) -
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2018) -
Diversity of Eukaryotic Translational Initiation Factor eIF4E in Protists
por: Jagus, Rosemary, et al.
Publicado: (2012) -
The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
por: Amorim, Inês S., et al.
Publicado: (2018) -
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
por: Ghram, Mehdi, et al.
Publicado: (2023)